- Home
- ALGS vs BOF Comparison
ALGS vs BOF Comparison
Compare ALGS & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | BOF |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6M | 33.8M |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ALGS | BOF |
|---|---|---|
| Price | $2.11 | $1.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $36.88 | N/A |
| AVG Volume (30 Days) | 55.4K | ★ 121.0K |
| Earning Date | 11-06-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | 31.33 |
| EPS | N/A | ★ N/A |
| Revenue | $2,186,000.00 | ★ $3,184,018.00 |
| Revenue This Year | $1,433.30 | $15.23 |
| Revenue Next Year | N/A | $100.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 258.20 |
| 52 Week Low | $2.02 | $1.58 |
| 52 Week High | $13.69 | $5.25 |
Technical Indicators
Market Signals| Indicator | ALGS | BOF |
|---|---|---|
| Relative Strength Index (RSI) | 18.06 | 21.76 |
| Support Level | N/A | $1.59 |
| Resistance Level | $7.79 | $4.00 |
| Average True Range (ATR) | 0.55 | 0.15 |
| MACD | -0.29 | 0.05 |
| Stochastic Oscillator | 1.45 | 14.94 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients. The products are mainly sold through three channels: branded retail snack products, private label products for retailers, and fruit and vegetable ingredients sold to food manufacturers.